Nice

News

NICE launches scientific advice tie-up with Canadian agency

The UK’s cost-effectiveness regulator NICE and the its counterpart in Canada have launched a new collaboration to offer parallel scientific advice to the life sciences industry.

News

Vertex calls for changes to NICE as CF drug profits soar

Vertex has revealed financial figures that are likely to go down well with investors, but not patients in the UK who are eligible to receive the revolutionary drugs like Orkambi yet are bei

News

NICE approves Novartis' CAR-T therapy for diffuse large B-ce...

NICE has approved Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for diffuse large B-cell lymphoma (DLBCL) in adults who did not respond to two or more previous treatments.

News

NICE aims to improve communications with UK life sciences

NICE has announced a collaboration with an organisation representing UK life sciences, to improve communications between the cost-effectiveness body and industry.

Views & Analysis

Market access roundup: The US fights back against price hike...

Don’t expect the US government’s war on drug pricing to go away any time soon – for once president Trump and his rivals, the Democrat party, agree on something, and both have had some stron

News

NICE assessments could reform in new superbug plan

The UK government has published a new five year plan aimed at tackling antimicrobial resistance (AMR), including a new NHS reimbursement scheme backed by NICE to encourage pharma to develop